Thread View: chi.news
1 messages
1 total messages
Started by genetic
Wed, 23 Feb 2000 00:00
NEOT - patents genetic Nerve Regeneration/sprouting technology
Author: genetic
Date: Wed, 23 Feb 2000 00:00
Date: Wed, 23 Feb 2000 00:00
35 lines
1224 bytes
1224 bytes
x x Today NeoTherapeutics(NASDAQ: NEOT) announced it now x holds patents on genetic technology that allows for nerve regeneration and nerve sprouting x Full Story: http://biz.yahoo.com/prnews/000223/ca_neot_ne_1.html U.S. Patent No. 6,027,936 describes how certain purine derivatives, a class of drug compounds which includes NeoTherapeutics' lead compound NEOTROFIN(TM) (AIT-082, leteprinim potassium), stimulate neuritogenesis, or the sprouting of nerve cells, by selectively and controllably inducing the in vivo genetic expression of at least one naturally occurring genetically- encoded molecule. x Contact: x Stephen Runnels NeoTherapeutics, Inc. x Phone: (949) 788-6700 Fax: (949) 788-6706 Email: cgruetter@neotherapeutics.com
Thread Navigation
This is a paginated view of messages in the thread with full content displayed inline.
Messages are displayed in chronological order, with the original post highlighted in green.
Use pagination controls to navigate through all messages in large threads.
Back to All Threads